logo
AI-powered exoskeletons are helping paralyzed patients walk again — and could soon be coming to homes across the U.S.

AI-powered exoskeletons are helping paralyzed patients walk again — and could soon be coming to homes across the U.S.

New York Post5 days ago
Inside the glass-ensconced Wandercraft storefront on Park Avenue South, Caroline Laubach recently rose from her wheelchair and walked.
'Every time I get up I remember how tall I really am,' Laubach, a 22-year-old from Pennsylvania, told NYNext.
At age 18, Laubach went into end-stage heart failure. For two weeks, she lingered on life support while doctors scrambled to find a donor. She ultimately had a successful heart transplant, but not before a spinal stroke left her paralyzed from the waist down.
10 Three years after a spinal stroke left her paralyzed, Caroline Laubach now walks weekly with the help of an exoskeleton from Wandercraft called Eve.
Emmy Park
She thought she would be confined to a wheelchair for the rest of her life, then she met Wandercraft's Atalante. During a therapy session in November 2024, she strapped on the exoskeleton for the first time. It was life-changing.
'To look at somebody from eye-level and have a connection with them in that way,' she said. 'It's a different dynamic.'
10 In December 2023, Wandercraft debuted its flagship U.S. space — a street-level showroom and clinic called Walk In New York.
Emmy Park
Founded in 2012, the French robotics and AI company Wandercraft launched its first model of Atalante in 2019. The device received FDA clearance for stroke rehabilitation two years later.
In December 2023, Wandercraft opened a headquarters and showroom in New York. It's betting that its exoskeletons can help redefine mobility for people with spinal cord injuries, strokes and other conditions affecting gait and balance.
'We are not just a technology [confined to] cool video demonstrations in the lab,' Matthieu Masselin, CEO and co-founder of Wandercraft, told NYNext. 'We are working with real people, real patients.'
10 'I was born completely healthy — as far as we knew,' Caroline Laubach (left) told NYNext's Lydia Moynihan (right). At 18, Laubach went into end-stage heart failure and spent two weeks on life support awaiting a transplant. During that time, she suffered a spinal stroke that left her paralyzed from the waist down.
Emmy Park
10 Laubach can control Eve with a handheld joystick, using buttons to walk forward, turn, squat and even bend side to side — all without assistance.
Emmy Park
Unlike other exoskeletons that require crutches, both Atalante and Wandercraft's newer model, Eve, are fully self-balancing. The former is designed specifically for physical therapy and requires the assistance of a clinician. The latter, now in clinical trials at the Bronx VA and Kessler Rehabilitation Center in New Jersey, can be fully controlled by the user and is built for personal use in home and real-world environments.
Wandercraft's exoskeletons are powered by multiple motors — two at the ankles, one at each knee and several at the hips — plus a suite of sensors that constantly track weight distribution. As the user shifts or moves, the system processes inputs in real time to maintain balance and posture.
10 While Atalante (right) is used in rehab centers under therapist supervision, Eve (left) is untethered, joystick-controlled and intended for everyday use outside the clinic.
Emmy Park
10 Masselin, who co-founded Wandercraft in 2012, left Paris and moved to New York about three years ago to help bring the company's vision to life in the U.S.
Emmy Park
From weight and height to balance and stride, every patient moves differently.
To ensure safety, Wandercraft has spent more than a decade refining its control algorithms and AI systems with collaborators like Nvidia and AWS. It's tested its hardware with more than 2,000 patients in hospitals and rehab centers.
10 French paraplegic tennis player Kevin Piette wore a Wandercraft exoskeleton while carrying the Olympic torch through Paris ahead of the 2024 Games.
Courtesy of Wandercraft
One prominent patient is French paraplegic tennis player Kevin Piette, who donned a Wandercraft exoskeleton to carry the Olympic torch towards Paris ahead of the 2024 Games.
'Emotionally, psychologically, physiologically … [we're seeing] the benefits on so many aspects of [the patients'] lives,' Masselin said.
10 Thanks to improved engineering and streamlined production, Wandercraft's exoskeletons are steadily becoming cheaper to produce — and a new partnership with the Renault Group, Masselin said, will drive costs down even further.
Emmy Park
Wandercraft devices are currently used in more than 100 institutions across Europe and America, and access is expanding.
The company recently received Medicare coding for Atalante, meaning qualifying patients will be reimbursed. When Eve hits the market,potentially as soon as next year, it will be eligible for reimbursement up to $93,000.
10 As part of its partnership with the Renault Group, Wandercraft has co-developed CALVIN-40 — a humanoid robot that can support manufacturing workflows.
Courtesy of Wandercraft
10 Masselin said that future iterations of the exoskeletons will be equipped for less even terrain and consistent surfaces like stairs and sand.
Emmy Park
To help scale, Wandercraft partnered with the Renault Group in June to streamline manufacturing and reduce costs. As part of the partnership, Wandercraft is also developing a new line of humanoid robots that can slot into the manufacturing process.
To Masselin, who relocated from Paris three years ago to lead US expansion, the future of the technology lies in its adaptation to broader environments — stairs, outdoor terrain, even beaches — and in building devices that respond to how people actually live.
This story is part of NYNext, an indispensable insider insight into the innovations, moonshots and political chess moves that matter most to NYC's power players (and those who aspire to be).
Laubach, for her part, hopes to be among the first to take Eve home once FDA clearance is granted.
'I hope we see a lot more exoskeletons out on the street,' she told NYNext, 'for people like me — and people very different from me.'
Send NYNext a tip: nynextlydia@nypost.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Important Notice of Dividend Announcement to shareholder of Xtrackers (IE) plc
Important Notice of Dividend Announcement to shareholder of Xtrackers (IE) plc

Business Wire

timean hour ago

  • Business Wire

Important Notice of Dividend Announcement to shareholder of Xtrackers (IE) plc

LONDON--(BUSINESS WIRE)-- Registered in Dublin, Ireland as an open-ended variable capital umbrella investment company with limited liability and as an umbrella fund with segregated liability between sub-funds. Registration Number 393802. Registered Office as above. Directors: Tom Murray (Irish), Michael Whelan (Irish), Gerry Grimes (Irish), Philippe Ah-Sun (British), Julien Boulliat (French) and Roberto Cesca (Italian). Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (the ' Company ') Important Notice to Shareholders of the Company Dividend Announcement 5 August 2025 Dividend announcement with regard to the following Funds of the Company The Board of Directors wishes to inform Shareholders that a dividend per share for certain Classes of Shares and Funds will be paid, as set out below. Please note the following dates which apply to all of the below: Ex-dividend date: 20 August 2025 Record date: 21 August 2025 Payment date: 4 September 2025 Fund Xtrackers MSCI World Screened UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.1116 ISIN Code IE00BCHWNQ94 Expand Fund Xtrackers MSCI USA Energy UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.6232 ISIN Code IE00BCHWNS19 Expand Fund Xtrackers MSCI USA Financials UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.2258 ISIN Code IE00BCHWNT26 Expand Fund Xtrackers MSCI USA Health Care UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.3933 ISIN Code IE00BCHWNW54 Expand Fund Xtrackers MSCI USA Minimum Volatility UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.3714 ISIN Code IE00BDB7J586 Expand Fund Xtrackers USD High Yield Corporate Bond UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.1958 ISIN Code IE00BDR5HM97 Expand Fund Xtrackers MSCI USA Banks UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.3137 ISIN Code IE00BDVPTJ63 Expand Fund Xtrackers ESG USD Emerging Markets Bond Quality Weighted UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.2418 ISIN Code IE00BD4DX952 Expand Fund Xtrackers USD Corporate Bond Short Duration SRI PAB UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.3386 ISIN Code IE00BF8J5974 Expand Fund Xtrackers MSCI USA Consumer Staples UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.4785 ISIN Code IE00BGQYRQ28 Expand Fund Xtrackers MSCI USA Consumer Discretionary UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.2194 ISIN Code IE00BGQYRR35 Expand Fund Xtrackers MSCI USA Information Technology UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.2305 ISIN Code IE00BGQYRS42 Expand Fund Xtrackers S&P Europe ex UK UCITS ETF Share Class 1D Denomination Currency EUR Amount/Share (gross) 1.2498 ISIN Code IE00BGV5VM45 Expand Fund Xtrackers MSCI World UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.4923 ISIN Code IE00BK1PV551 Expand Fund Xtrackers MSCI Japan Screened UCITS ETF Share Class 1D Denomination Currency JPY Amount/Share (gross) 25.5250 ISIN Code IE00BPVLQD13 Expand Fund Xtrackers MSCI Japan Screened UCITS ETF Share Class 2D - GBP Hedged Denomination Currency GBP Amount/Share (gross) 0.2477 ISIN Code IE00BPVLQF37 Expand Fund Xtrackers USD Corporate Bond UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.1484 ISIN Code IE00BZ036H21 Expand Fund Xtrackers MSCI World UCITS ETF Share Class 2D - GBP Hedged Denomination Currency GBP Amount/Share (gross) 0.1071 ISIN Code IE00BZ1BS790 Expand Fund Xtrackers MSCI Nordic UCITS ETF Share Class 1D Denomination Currency EUR Amount/Share (gross) 1.1481 ISIN Code IE00B9MRHC27 Expand Fund Xtrackers MSCI USA Industrials UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.4638 ISIN Code IE00BCHWNV48 Expand Fund Xtrackers MSCI USA Communication Services UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.3070 ISIN Code IE00BNC1G707 Expand Fund Xtrackers MSCI Emerging Markets UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.0726 ISIN Code IE000GWA2J58 Expand Fund Xtrackers S&P 500 Equal Weight UCITS ETF Share Class 1D - GBP Hedged Denomination Currency GBP Amount/Share (gross) 0.0252 ISIN Code IE000N5GJDD7 Expand Fund Xtrackers USD Corporate Green Bond UCITS ETF Share Class 1D - GBP Hedged Denomination Currency GBP Amount/Share (gross) 0.1696 ISIN Code IE000X63FXN4 Expand Fund Xtrackers MSCI USA ESG UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.0222 ISIN Code IE000UMV0L21 Expand Fund Xtrackers USD High Yield Corporate Bond UCITS ETF Share Class 4D - GBP Hedged Denomination Currency GBP Amount/Share (gross) 0.1081 ISIN Code IE00BG04LV15 Expand Fund Xtrackers MSCI USA Climate Transition UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.1112 ISIN Code IE000GYDNJS5 Expand Fund Xtrackers MSCI Japan Climate Transition UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.0402 ISIN Code IE0006FDYJF8 Expand Fund Xtrackers S&P 500 Equal Weight UCITS ETF Share Class 2D Denomination Currency USD Amount/Share (gross) 0.2938 ISIN Code IE000CXLGK86 Expand Fund Xtrackers USD Corporate Bond UCITS ETF Share Class 5D - GBP Hedged Denomination Currency GBP Amount/Share (gross) 0.0848 ISIN Code IE00BG04LY46 Expand Fund Xtrackers MSCI USA High Dividend Yield ESG UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.1429 ISIN Code IE000V04SL39 Expand Fund Xtrackers MSCI World High Dividend Yield ESG UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.3040 ISIN Code IE000NS5HRY9 Expand Fund Xtrackers MSCI World ex USA UCITS ETF Share Class 1D Denomination Currency USD Amount/Share (gross) 0.1083 ISIN Code IE000Z0FC0G5 Expand Should you have any queries in this regard please do not hesitate to contact your relationship manager directly. Capitalised terms used in this letter shall have the meaning ascribed to them in the current Prospectus of the Company unless the context otherwise requires. We thank you for your continuing support of the Company. Yours faithfully, _______________ Director For and on behalf of Xtrackers (IE) plc Contact Information Xtrackers (IE) plc 78 Sir John Rogerson's Quay Dublin 2, Ireland

Vertex Falls After FDA Doubts Broad Use of Chronic Pain Drug
Vertex Falls After FDA Doubts Broad Use of Chronic Pain Drug

Bloomberg

time2 hours ago

  • Bloomberg

Vertex Falls After FDA Doubts Broad Use of Chronic Pain Drug

Vertex Pharmaceuticals Inc. shares fell 15% after an experimental pain drug failed to benefit patients after surgery and US regulators said they didn't see a path forward for broad use of its pill in treating a chronic pain condition. Vertex has been trying to diversify beyond its core business of cystic fibrosis treatments. A key part of that strategy has been its new non-opioid pain drug, Journavx, which got US regulatory clearance in January. It was the first new type of painkiller to reach the US market in more than two decades.

E-Invoicing: Quadient Reaches Key Milestone as Serensia Successfully Passes French Tax Authority Testing
E-Invoicing: Quadient Reaches Key Milestone as Serensia Successfully Passes French Tax Authority Testing

Business Upturn

time3 hours ago

  • Business Upturn

E-Invoicing: Quadient Reaches Key Milestone as Serensia Successfully Passes French Tax Authority Testing

E-Invoicing: Quadient Reaches Key Milestone as Serensia Successfully Passes French Tax Authority Testing Quadient (Euronext Paris: QDT), a global intelligent automation platform enabling secure and professional business connections, announced today that Serensia, its recent acquisition in the digital segment, has successfully completed interoperability testing in live conditions as part of France's phased rollout of mandatory e-invoicing. Serensia, a certified French e-invoicing platform connected to the Peppol network, was selected by the French Public Finance Department, along with two other platforms, formerly designated as Partner Dematerialization Platforms (PDP) and now referred to as Certified Platforms, to participate in the first round of interoperability testing. Conducted under real-world conditions, the tests validated the public directory's interaction with other platforms and the government's data hub. Beyond demonstrating technical capabilities, the initiative reflects a broader commitment to strengthening collaboration between private-sector players and public authorities. The results confirm Serensia's robustness, reliability and compliance, marking a major step forward in Quadient's readiness and reaffirming its ability to support businesses in meeting the requirements of the e-invoicing reform. 'The French Public Finance Department's selection of Serensia for the initial round of real-world testing speaks to the strength of the solution,' said Geoffrey Godet, CEO of Quadient. 'Its successful compliance testing validates the strategic choices we've made, particularly the acquisition of Serensia, which now positions Quadient at the forefront of the reform's implementation across all French companies. Our message to businesses is clear: transitioning to e-invoicing requires preparation, and Quadient is more ready than ever to support them with a proven, reliable and compliant solution.' As of July 1, the central directory listing all VAT-registered businesses has gone live. Quadient is already able to register clients who have granted it a mandate, in accordance with the government-defined process. Through its subsidiary Serensia or its own certified platform, the company is preparing for its final registration, expected in fall 2025. This will enable it to fully support large enterprises, mid-sized companies, SMEs and accounting firms in the digital transition mandated by the reform. To learn more about Quadient's invoicing and payment solutions, visit: About Quadient® Quadient is a global automation platform powering secure and sustainable business connections through digital and physical channels. Quadient supports businesses of all sizes in their digital transformation and growth journey, unlocking operational efficiency and creating meaningful customer experiences. Listed in compartment B of Euronext Paris (QDT) and part of the CAC® Mid & Small and EnterNext® Tech 40 indices, Quadient shares are eligible for PEA-PME investing. For more information about Quadient, visit Media Contacts Joe Scolaro, QuadientGlobal Press Relations Manager+1 203-301-3673 [email protected]

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store